Passari Ajit K, Chandra Preeti, Leo Vincent V, Mishra Vineet K, Kumar Brijesh, Singh Bhim P
Molecular Microbiology and Systematics Laboratory, Department of Biotechnology, Mizoram University Aizawl, India.
CSIR-Central Drug Research Institute, Sophisticated Analytical Instrument Facility Lucknow, India.
Front Microbiol. 2017 Jan 25;8:68. doi: 10.3389/fmicb.2017.00068. eCollection 2017.
The genus under phylum actinobacteria has been recognized as a prolific source for the production of bioactive secondary metabolites. An actinobacterial strain designated as DST103 isolated from a wetland fresh water sediment of Tamdil Lake, Mizoram, Northeast, India was identified as (KY287599) using 16SrRNA gene sequencing which shares 99.87% sequence similarity with NRRL B-2570 . The strain showed broad spectrum antimicrobial activities against Gram negative bacteria ( MTCC 739 and MTCC 2453), Gram positive bacteria ( NCIM 2170 and MTCC 96) and yeast pathogen MTCC 3017). The methanolic extract of the strain DST103 exhibited highest antimicrobial activity against (IC = 2.10 μg/mL) and minimum activity against (IC = 43.63 μg/mL). Five antibiotics [trimethoprim (18 μg/g), fluconazole (6 μg/g), ketoconazole (18 μg/g), nalidixic acid (135 μg/g), and rifampicin (56 μg/g)] were detected and quantified using ultra-performance liquid chromatography (UPLC-ESI-MS/MS). Further, biosynthetic potential genes [polyketide synthases type II, non-ribosomal peptide synthetases, and aminodeoxyisochorismate synthase (E)] were also detected in strain DST103 which may possibly be responsible for the production of antimicrobial compounds. Additionally, gas chromatography-mass spectrometry analysis showed the presence of four volatile compounds which might be responsible for their diverse biological activity. The present study revealed the presence of bioactive compounds in strain DST103, which may be a promising resource for the discovery of novel bioactive metabolites against wide range of pathogens.
放线菌门下的该属已被公认为是生物活性次级代谢产物的丰富来源。从印度东北部米佐拉姆邦坦迪尔湖的湿地淡水沉积物中分离出的一株放线菌菌株DST103,通过16SrRNA基因测序被鉴定为(KY287599),其与NRRL B - 2570的序列相似性为99.87%。该菌株对革兰氏阴性菌(MTCC 739和MTCC 2453)、革兰氏阳性菌(NCIM 2170和MTCC 96)以及酵母病原体MTCC 3017表现出广谱抗菌活性。菌株DST103的甲醇提取物对(IC = 2.10 μg/mL)表现出最高抗菌活性,对(IC = 43.63 μg/mL)表现出最低活性。使用超高效液相色谱(UPLC - ESI - MS/MS)检测并定量了五种抗生素[甲氧苄啶(18 μg/g)、氟康唑(6 μg/g)、酮康唑(18 μg/g)、萘啶酸(135 μg/g)和利福平(56 μg/g)]。此外,在菌株DST103中还检测到了生物合成潜在基因[II型聚酮合酶、非核糖体肽合成酶和氨基脱氧异分支酸合酶(E)],这些基因可能是抗菌化合物产生的原因。另外,气相色谱 - 质谱分析表明存在四种挥发性化合物,它们可能是其多种生物活性的原因。本研究揭示了菌株DST103中存在生物活性化合物,这可能是发现针对多种病原体的新型生物活性代谢物的有前途的资源。